{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:31:08Z","timestamp":1770903068639,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1245\/s10434-025-18544-7","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T13:37:00Z","timestamp":1760881020000},"page":"2507-2514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of First Versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma"],"prefix":"10.1245","volume":"33","author":[{"given":"Naaz","family":"Nasar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misha","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne F.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithat","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod P.","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Drebin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Peter","family":"Kingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice C.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remo","family":"Alessandris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan K.","family":"Abou-Alfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wungki","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,19]]},"reference":[{"issue":"5","key":"18544_CR1","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cncr.29824","volume":"122","author":"IT Konstantinidis","year":"2016","unstructured":"Konstantinidis IT, Groot Koerkamp B, Do RK, et al. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Cancer. 2016;122(5):758\u201365.","journal-title":"Cancer."},{"issue":"1","key":"18544_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","volume":"248","author":"I Endo","year":"2008","unstructured":"Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84\u201396.","journal-title":"Ann Surg."},{"issue":"6","key":"18544_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.21037\/jgo.2018.07.09","volume":"9","author":"K Mody","year":"2018","unstructured":"Mody K, Antwi SO, Hodge DO, Ailawadhi S, Roberts L, Bekaii-Saab T. A SEER-based multi-ethnic picture of advanced intrahepatic cholangiocarcinoma in the United States pre- and post-the advent of gemcitabine\/cisplatin. J Gastrointest Oncol. 2018;9(6):1063\u201373. https:\/\/doi.org\/10.21037\/jgo.2018.07.09.","journal-title":"J Gastrointest Oncol."},{"issue":"4","key":"18544_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/sj.bjc.6605211","volume":"101","author":"JW Valle","year":"2009","unstructured":"Valle JW, Wasan H, Johnson P, et al. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer. 2009;101(4):621\u20137.","journal-title":"Br J Cancer."},{"issue":"14","key":"18544_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med."},{"key":"18544_CR6","doi-asserted-by":"publisher","unstructured":"Oh DY, Ruth He A, Qin S, et al. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.\u00a0NEJM Evid. 2022;1(8):EVIDoa2200015. https:\/\/doi.org\/10.1056\/EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015"},{"issue":"10391","key":"18544_CR7","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401(10391):1853\u201365. https:\/\/doi.org\/10.1016\/S0140-6736(23)00727-4.","journal-title":"Lancet."},{"issue":"1","key":"18544_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","volume":"6","author":"A Cercek","year":"2020","unstructured":"Cercek A, Boerner T, Tan BR, et al. Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2020;6(1):60\u20137.","journal-title":"JAMA Oncol."},{"issue":"1","key":"18544_CR9","first-page":"115","volume":"31","author":"S Franssen","year":"2024","unstructured":"Franssen S, Holster JJ, Jolissaint JS, et al. Gemcitabine with cisplatin versus hepatic arterial infusion pump chemotherapy for liver-confined unresectable intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2024;31(1):115\u201324.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"18544_CR10","doi-asserted-by":"publisher","first-page":"12272","DOI":"10.1002\/cam4.5925","volume":"12","author":"KC Soares","year":"2023","unstructured":"Soares KC, Jolissaint JS, McIntyre SM, et al. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival. Cancer Med. 2023;12(11):12272\u201384.","journal-title":"Cancer Med."},{"issue":"7","key":"18544_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/jamasurg.2022.1298","volume":"157","author":"S Franssen","year":"2022","unstructured":"Franssen S, Soares KC, Jolissaint JS, et al. Comparison of hepatic arterial infusion pump chemotherapy vs resection for patients with multifocal intrahepatic cholangiocarcinoma. JAMA Surg. 2022;157(7):590\u20136.","journal-title":"JAMA Surg."},{"issue":"1","key":"18544_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1245\/s10434-021-10279-5","volume":"29","author":"AJ Rossi","year":"2022","unstructured":"Rossi AJ, Khan TM, Luna AJ, Cercek A, Jarnagin WR, Hernandez JM. Hepatic artery infusion pump (HAIP) therapy versus chemotherapy in the first-line setting for patients with unresectable intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2022;29(1):35\u20136.","journal-title":"Ann Surg Oncol."},{"key":"18544_CR13","doi-asserted-by":"publisher","unstructured":"Cowzer D, Soares K, Walch H, et al. Long term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy.\u00a0J Natl Cancer Inst. Published online September 27, 2024. https:\/\/doi.org\/10.1093\/jnci\/djae202.","DOI":"10.1093\/jnci\/djae202"},{"issue":"8","key":"18544_CR14","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/cncr.30488","volume":"123","author":"S Yamashita","year":"2017","unstructured":"Yamashita S, Koay EJ, Passot G, et al. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: a comprehensive analysis of 362 consecutive patients. Cancer. 2017;123(8):1354\u201362.","journal-title":"Cancer."},{"issue":"6","key":"18544_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1634\/theoncologist.8-6-553","volume":"8","author":"AD Cohen","year":"2003","unstructured":"Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist. 2003;8(6):553\u201366. https:\/\/doi.org\/10.1634\/theoncologist.8-6-553.","journal-title":"Oncologist."},{"issue":"8","key":"18544_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1001\/jamasurg.2019.1694","volume":"154","author":"J Datta","year":"2019","unstructured":"Datta J, Narayan RR, Kemeny NE, D\u2019Angelica MI. Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: a review. JAMA Surg. 2019;154(8):768\u201376. https:\/\/doi.org\/10.1001\/jamasurg.2019.1694.","journal-title":"JAMA Surg."},{"issue":"7","key":"18544_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJM200502173520723","volume":"352","author":"NE Kemeny","year":"2005","unstructured":"Kemeny NE, Gonen M. Hepatic Arterial Infusion after Liver Resection. New England J Med. 2005;352(7):734\u20135. https:\/\/doi.org\/10.1056\/NEJM200502173520723.","journal-title":"New England J Med."},{"key":"18544_CR18","doi-asserted-by":"publisher","unstructured":"D\u02bcAngelica MI, Correa-Gallego C, Paty PB, et al. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.\u00a0Ann Surg. 2015;261(2):353-360. https:\/\/doi.org\/10.1097\/SLA.0000000000000614","DOI":"10.1097\/SLA.0000000000000614"},{"key":"18544_CR19","doi-asserted-by":"crossref","unstructured":"Wright GP, Perkins S, Jones H, et al. Surgical resection does not improve survival in multifocal intrahepatic cholangiocarcinoma: a comparison of surgical resection with intra-arterial therapies. Ann Surg Oncol. 2018","DOI":"10.1245\/s10434-017-6110-1"},{"issue":"14","key":"18544_CR20","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1158\/1078-0432.CCR-21-0412","volume":"27","author":"JS Jolissaint","year":"2021","unstructured":"Jolissaint JS, Soares KC, Seier KP, et al. Intrahepatic cholangiocarcinoma with lymph node metastasis: treatment-related outcomes and the role of tumor genomics in patient selection. Clin Cancer Res. 2021;27(14):4101\u20138.","journal-title":"Clin Cancer Res."},{"key":"18544_CR21","doi-asserted-by":"crossref","unstructured":"Jarnagin WR, Schwartz LH, Gultekin DH, et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.\u00a0Ann Oncol. 2009","DOI":"10.1093\/annonc\/mdp029"},{"issue":"9","key":"18544_CR22","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1245\/s10434-022-11439-x","volume":"29","author":"JJ Holster","year":"2022","unstructured":"Holster JJ, El Hassnaoui M, Franssen S, et al. Hepatic arterial infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2022;29(9):5528\u201338.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"18544_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng DT, Mitchell TN, Zehir A, et al. Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn. 2015;17(3):251\u201364.","journal-title":"J Mol Diagn."},{"issue":"11","key":"18544_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","volume":"1","author":"JR Anderson","year":"1983","unstructured":"Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983;1(11):710\u20139. https:\/\/doi.org\/10.1200\/JCO.1983.1.11.710.","journal-title":"J Clin Oncol."},{"issue":"2","key":"18544_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/0962280208092301","volume":"18","author":"L Meira-Machado","year":"2009","unstructured":"Meira-Machado L, de U\u00f1a-Alvarez J, Cadarso-Su\u00e1rez C, Andersen PK. Multi-state models for the analysis of time-to-event data. Stat Methods Med Res. 2009;18(2):195\u2013222.","journal-title":"Stat Methods Med Res."},{"key":"18544_CR26","volume-title":"Survival analysis techniques for censored and truncated data (statistics for biology and health)","author":"V Klein","year":"1950","unstructured":"Klein V, et al. Survival analysis techniques for censored and truncated data (statistics for biology and health). 2nd edn. Cham: Springer; 1950.","edition":"2"},{"key":"18544_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/9781118032985","volume-title":"The statistical analysis of failure time data","author":"JD Kalbfleich","year":"2002","unstructured":"Kalbfleich JD, Prentice RL. The statistical analysis of failure time data. 2nd edn. Hoboken: Wiley; 2002.","edition":"2"},{"issue":"3\u20134","key":"18544_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000324704","volume":"80","author":"NE Kemeny","year":"2011","unstructured":"Kemeny NE, Schwartz L, G\u00f6nen M, et al. Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? Oncology. 2011;80(3\u20134):153\u20139. https:\/\/doi.org\/10.1159\/000324704.","journal-title":"Oncology."},{"issue":"2","key":"18544_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jnci\/djz071","volume":"112","author":"A Lamarca","year":"2020","unstructured":"Lamarca A, Ross P, Wasan HS, et al. Advanced intrahepatic cholangiocarcinoma: post hoc analysis of the ABC-01, -02, and -03 clinical trials. J Natl Cancer Inst. 2020;112(2):200\u201310. https:\/\/doi.org\/10.1093\/jnci\/djz071.","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"18544_CR30","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.31829","volume":"74","author":"T Boerner","year":"2021","unstructured":"Boerner T, Drill E, Pak LM, et al. Genetic determinants of outcome in intrahepatic cholangiocarcinoma. Hepatology. 2021;74(3):1429\u201344. https:\/\/doi.org\/10.1002\/hep.31829.","journal-title":"Hepatology."},{"key":"18544_CR31","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Statist Med. 2007;26:2389\u2013430. https:\/\/doi.org\/10.1002\/sim.2712.","journal-title":"Statist. Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18544-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:40:07Z","timestamp":1770900007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18544-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,19]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["18544"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18544-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,19]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All other authors have nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}